ACRS - Aclaris Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ACRS is currently covered by 7 analysts with an average price target of $13.11. This is a potential upside of $11.89 (974.59%) from yesterday's end of day stock price of $1.22.

Aclaris Therapeutics's activity chart (see below) currently has 30 price targets and 45 ratings on display. The stock rating distribution of ACRS is 34.78% HOLD and 65.22% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.73% with an average time for these price targets to be met of 83.55 days.

Highest price target for ACRS is $2, Lowest price target is $1, average price target is $13.11.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 22-Jan-2024. First documented stock forecast 02-Nov-2015.

Currently out of the existing stock ratings of ACRS, 8 are a HOLD (34.78%), 15 are a BUY (65.22%).

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


3 months 11 days ago

0/2 (0%)

$21.59 (291.36%)



3 months 12 days ago

0/4 (0%)

$0.49 (48.51%)



$-0.19 (-15.97%)


4 months 4 days ago

1/4 (25%)

$0.06 (6.38%)




5 months 8 days ago

0/7 (0%)

$23.92 (169.89%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACRS (Aclaris Therapeutics) average time for price targets to be met?

On average it took 83.55 days on average for the stock forecasts to be realized with a an average price target met ratio 22.73

Which analyst has the current highest performing score on ACRS (Aclaris Therapeutics) with a proven track record?


Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?

David Steinberg has 5 price targets and 3 ratings on ACRS

Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?

Corinne Jenkins with highest potential upside - $19.81

Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?

Alex Thompson with lowest potential downside - -$0.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?